LianBio American Depositary Shares
World Rank (Jan-05-2024)
13,238
Market Cap (Jan-05-2024)
0.451 Billion USD
World Rank (Jul-30-2023)
17,654
Market Cap (Jul-30-2023)
0.216 Billion USD
World Rank (Dec-25-2022)
18,679
Market Cap (Dec-25-2022)
0.177 Billion USD
World Rank (Jan-07-2022)
13,160
Market Cap (Jan-07-2022)
0.53 Billion USD
Annual Revenue in USD
0 Million USD
Annual Net Income in USD
-196 Million USD
Annual Results for Period Ending
Dec-2021 ending year
Company Profile
LianBio is a biopharmaceutical company that treat the specific cause of diseases like cardiovascular, oncology and respiratory. The company total assets are 279.2 million USD as on 2020. The headquarters is in USA.
Company Website